NCT00217737 2026-03-18
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
79 trialsNCT00980460 2026-03-18
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT02997228 2026-03-18
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT03375320 2026-03-18
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT01013649 2026-02-23
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT01196390 2026-02-18
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT02912559 2026-02-02
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00002968 2025-12-29
Edrecolomab in Treating Patients With Stage II Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01004978 2024-01-03
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT01015833 2022-08-04
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00079274 2020-05-13
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00339768 2019-12-12
A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00096278 2019-07-30
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00068692 2018-12-04
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00324987 2017-09-14
S0502
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00009906 2014-12-23
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00499369 2014-07-31
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00008281 2014-01-06
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002615 2013-12-19
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002692 2013-12-19
Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002893 2013-12-19
Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00008060 2013-12-19
Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00021281 2013-12-19
Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005586 2013-12-18
Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
National Cancer Institute (NCI)
Phase 3 Completed
NCT00058201 2013-12-18
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00079027 2013-12-18
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00617071 2013-12-18
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00893295 2013-12-18
Increasing Colorectal Cancer Screening in African Americans
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003354 2013-12-04
Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003422 2013-12-04
Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003912 2013-12-04
Chemotherapy in Treating Children With Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00005869 2013-12-04
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005870 2013-12-04
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005871 2013-12-04
Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00004150 2013-11-06
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003835 2013-10-08
Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002896 2013-09-20
Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002897 2013-09-20
Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003063 2013-09-20
Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003617 2013-09-20
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00027768 2013-09-20
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002793 2013-09-17
Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00007930 2013-08-26
Comparison of Two Types of Surgery in Treating Patients With Rectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00025090 2013-08-26
Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00363584 2013-08-26
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00425360 2013-08-26
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00427713 2013-08-26
Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002455 2013-08-07
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002884 2013-08-07
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
National Cancer Institute (NCI)
Phase 3 Unknown